SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT South East SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11246
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology consulting and licensing services. It also manages the portfolios of intellectual property of several organizations. The company offers services in areas of digital and connected information society, health and life technologies; environment, energy and territories, industrial processing, and culture, heritage and digital humanities. It serves materials, environment and information technologies such as hardware and embedded, multimedia, data processing, software engineering, chemistry process, material and mechanical engineering, energy, optical, environment and other sectors. SATT South East is headquartered in Marseille, France.

SATT South East SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SATT South East SAS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Licensing Agreements 13
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS – Key Competitors 18
SATT South East SAS – Key Employees 19
SATT South East SAS – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
SATT South East SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS, Key Competitors 18
SATT South East SAS, Key Employees 19

List of Figures
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nihon Kohden Corporation:戦略・SWOT・企業財務分析
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • MKB Private Banking:企業の戦略・SWOT・財務情報
    MKB Private Banking - Strategy, SWOT and Corporate Finance Report Summary MKB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Medicago Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. I …
  • Kansas Electric Power Cooperative Inc:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Immunomedics Inc (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops its candidates based on its proprietary technol …
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773):製薬・医療:M&Aディール及び事業提携情報
    Summary Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company that develops, manufactures and markets Chinese medicines, chemical drugs and biological products. The company offers products for the treatment of medical conditions related to centr …
  • EOG Resources Inc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary EOG Resources Inc (EOG) is an independent upstream oil and gas company. The company, along with its subsidiaries, explores for, develops and produces crude oil and natural gas. EOG has operations in the US, Canada, Trinidad, the UK and China. Its holds licenses for assets in in Eagle Ford, B …
  • Tokyo Broadcasting System Holdings Inc (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • Cleco Corporate Holdings LLC:発電所・企業SWOT分析
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Albertsons Companies, Inc.:戦略・SWOT・企業財務分析
    Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Albertsons Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Nevro Corp (NVRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Darden Restaurants, Inc.:戦略・SWOT・企業財務分析
    Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Apollo Minerals Ltd:企業の戦略・SWOT・財務情報
    Apollo Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary Apollo Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Capita plc:企業の戦略・SWOT・財務情報
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • PixCell Medical Technologies Ltd:企業の製品パイプライン分析
    Summary PixCell Medical Technologies Ltd (PixCell) is a medical device company that develops, produces and markets portable medical diagnostic products for point of care testing. The company’s product comprises hemoscreen, a portable hematology analyzer used for blood sampling and analysis. Its hemo …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆